Dear Reader,
This issue of Human Vaccines & Immunotherapeutics begins with 47 articles on the Coronavirus.
These include two mini-reviews on ethical aspects of vaccine trials (Kumar, p 3843) and the association of vaccine coverage and reproduction number (Elsaid, p 3850) and a full review of the development of synthetic-antigen vaccines (Viana Invenção, p 3855).
There are research reports on vaccine administration workflow in US (Yarnoff, p 3871), immunogenicity of the inactivated vaccine Coronavac (Soysal, p 3876), adverse reactions in healthcare workers (HCWs) in Ghana (Serwaa, p 3881), trends in publications on vaccine safety (Akintunde, p 3887), vaccination experience in Indonesia (Arifin, p 3898), willingness to participate in a vaccine trial (Ridde, p 3907), effectiveness of BCG booster for preventing Covid-19 (Amirlak, p 3913), vaccine information in Spanish on YouTube (Hernandez-Garcia, p 3916), vaccine attitudes in Quebec Canada (Dubé, p 3922), in nurses in Hawaii (Fontenot, p 3933), in North India (Husain, p 3941), in Japan (Machida, p 3954), and in China (Zhang, p 3963), and among parents of young children in China (Wan, p 3969), gender differences in willingness to get the vaccine (Ishimaru, p 3975), maternal vaccine awareness (Chinawa, p 3982), hindrances to a successful campaign in Brazil (Boschiero, p 3989), hesitancy among Chinese adults (Shen, p 4005), in New York (Smith-Norowitz, p 4013), in Saudi Arabia (Yahia, p 4015), among medical students (Li, p 4021), in Bangladesh (Hossain, p 4028), and in Shanghai (Wu, p 4038), among mothers in the postpartum period (Oluklu, p 4043), and among rheumatic patients (Ko, p 4048), in Nigeria (Iliyasu, p 4057), vaccine status and acceptability among HCWs in China (Li, p 4065) and UAE students (Alzubaidi, p 4074), and prevalence of vaccine-preventable diseases during the pandemic (Sun, p 4083).
Case reports address post-vaccination subacute thyroiditis (Şahin Tekin, p 4090), Guillain-Barré syndrome (Scendoni, p 4093), pityriasis rosea (Cohen, p 4097), acute CNS demyelination (Mirmosayyeb, p 4099) and conjunctival congestion (Jin, p 4102).
Two commentaries relate to fighting vaccine hesitancy in chronically ill patients (Campanati, p 4105) and to vaccine passports (Sharun, p 4108).
Letters to the Editor focus on vaccine safety in subjects with fructose intolerance (Urru, p 4112; Reply Letter in Saborido-Fiaño, p 4115), fake vaccines in India (Choudhary, p 4117), lessons learned for future pandemics (EL-Arabey, p 4119), possible antibody-dependent enhancement of disease caused by future SARS-CoV-2 strains (Hasan, p 4121), the Delta variant in the pandemic’s second wave (Tareq, p 4126), the biochemistry of the spike protein (Kumar, p 4128), and India’s vaccine self-sufficiency (Shekhar, p 4131).
The Licensed Vaccines section presents reviews on the use of zoster vaccine in immunocompromised subjects (Dagnew, p 4132) and in outpatient clinics in India (Patki, p 4155), a survey of acceptability of zoster vaccine in Shanghai (Lu, p 4163), analysis of the impact of routine varicella vaccination in Japan (Kuniyoshi, p 4171), two Phase 3 trials of the immunogenicity of varicella vaccine in adults (Paradis, p 4177) and children (Paradis, p 4183), comparison of immunogenicity of different varicella vaccines in children (Umit, p 4190), economic evaluation of varicella vaccination strategies China (Wang, p 4194), a report on MMR serostatus in China (Wang, 4203), a mini-review on the impact of the Disneyland measles outbreak (Doll, p 4210), a study of impact vaccine subsidy program in Japan (Miyazaki, p 4216), investigation of DTP adverse events following the introduction of the acellular pertussis vaccine in Chile (Aguirre-Boza, p 4225), a survey of attitudes to maternal pertussis vaccination in Japan (Hiiragi, p 4235), safety and immunogenicity trial of post-exposure rabies vaccination (Shankaraiah, p 4239), literature reviews on Ebola vaccine research (Akintunde, p 4246), safety of JEV vaccines (Hu, p 4259) and recommendations for adult vaccination in Italy (Andreoni, p 4265), a survey among Italian experts on the role of vaccines in combating antimicrobial resistance (Marchetti, p 4283), a study of vaccine coverage among type 1 diabetes patients (Giatraki, p 4291), and a meeting report from the 11th TIPICO conference (Martinón-Torres, p 4299).
Five articles on Immunotherapy include a review of the use of improved Fc fragment in antiviral defense (Gunn, p 4328), a product review on MAbs for treatment of multiple sclerosis (Gabelić, p 4345), a study of DC-targeting immunotherapy for renal-cell carcinoma (Ma, p 4363), a review of CAR-based immunotherapies (Yuan, p 4374), and analysis of correlates of efficacy of vaccines for opioid use disorders (Crouse, p 4383).
The HPV segment features research reports on the sexual and prevention behaviors of (un)vaccinated women (Sauvageau, p 4393), vaccine attitudes among students (Wang, p 4397), Chinese parent (Xie, p) and mothers of daughters (Han, p 4412), educational intervention in Japan (Miyoshi, p 4418), implementation of school-entry mandates in Puerto Rico (Colón-López, p 4423), vaccine reporting (Zhou, p 4433) and promotion (Chen, p 4442) on Chinese social media, and presence of HPV, EBV and MMTV in breast-cancer samples (Gupta, p 4457), and a Letter to the Editor on medical provider’s influence on vaccine uptake (Polonijo, p 4467).
The Acceptance section introduces reviews of determinants of vaccine uptake among adolescents (Cadeddu, p 4470) and nurses’ and pharmacists’ role in fighting hesitancy (Cassidy, p 4487), and research articles on correlates of parental hesitancy in Turkey (Yörük, p 4505), nurses’ vaccine knowledge and behaviors (Boz, p 4512), parental trust in health systems (Tal, p 4518), perception of mandatory vaccination in France (Mignot, p 4529), and coverage among Greek school children (Kanellopoulou, p 4535).
Three articles on Novel Vaccines include a review of maternal RSV vaccines (Gunatilaka, p 4542), a commentary on novel malaria vaccines (Laurens, p 4549), and a review on epidemiology of norovirus in China (Wei, p 4553).
The Hepatitis B section reports on vaccine use in HCWs (Stevenson, p 4567), safety and immunogenicity of vaccination in children with blood cancers (Deng, p 4578), infection markers and vaccine responses among students (Xu, p 4587), and Turkish students’ vaccine knowledge and behaviors (Acikgoz, p 4595).
The Influenza segment presents a cost-effectiveness analysis of adjuvanted quadrivalent vaccine in UK (Kohli, p 4603), a commentary on vaccination campaign during the pandemic in Australia (Van Buynder, p 4611), a report on adverse events due to quadri- and tri-valent vaccines in China (Lv, p 4617), and a survey of knowledge and attitudes to seasonal vaccination among HCWs in Lebanon (Alame, p 4623).
Four Rotavirus articles investigate statistical methods to estimate waning vaccine efficacy (Haber, p 4632), clinical experience with live-attenuated vaccine in Italy (Bonanni, p 4636), non-inferiority of liquid and lyophilized oral vaccines in infants (Cohet, p 4646), and a nosocomial gastroenteritis outbreak in a Brazilian pediatric hospital (Gutierrez, p 4654).
The Pneumococcal section features a comparison of protection following PCV-7 and PCV-13 vaccination (Mokaddas, p 4661), a commentary on disease surveillance in Latin America (Nieto Guevara, p 4667), and a Letter to the Editor on the increased demand for pneumococcal vaccines in Japan during the pandemic (Komori, p 4673).
A couple of Meningococcal articles include a review of epidemiology and vaccination among college students (Schaffer DeRoo, p 4675) and a comparison of different schedules for ABCWY vaccination in adolescents (Vesikari, p 4689).
Our monthly News, Policy and Profiles (NP&P) track offers a selection of the latest news in the field of vaccines and immunotherapeutics. In this section we also regularly publish opinion pieces on timely, interesting and controversial topics related to vaccines and immunotherapeutics, profiles of companies and organizations, as well as portraits of distinguished scientists in our field. Please contact Acquisitions Editor Adam Weiss ([email protected]) with your ideas for commentaries, opinion pieces, profiles and portraits. Your suggestions for and contributions to our NP&P track are always welcome!
Sincerely,
Ronald Ellis, PhD
Editor-in-Chief
Adam Weiss, PhD
Acquisitions Editor
Disclosure statement
No potential conflict of interest was reported by the author(s).